vrbpac

AMA Update 297: FDA approvals, CDC recommendations and WHO COVID announcement with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news from the World Health Organization, Centers for Disease Control and Prevention, and the Food and Drug Administration’s upcoming Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting this June. Including the U.S. Public Health Emergency (PHE) for COVID-19 ending on May 11, 2023. American Medical Association CXO Todd Unger hosts.

🦠 For more information and to register for «Infection Prevention and Control Post-COVID-19 PHE: A Town Hall with CDC’s Project Firstline» on May 11, visit: https://edhub.ama-assn.org/cdc-project-firstline/video-player/18780695

Read More

AMA Update 251: Bivalent vaccine effectiveness, COVID booster schedule and Evusheld update with Sandra Fryhofer, MD

AMA Board Chair Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup, recaps the latest news from the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting. Topics include the vote on “harmonizing” strain composition for both COVID-19 primary vaccines and booster shots, as well as an update about the preliminary stroke risk signal for seniors who received a Pfizer booster. American Medical Association CXO Todd Unger hosts.

Read More